U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
156331156331A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically IllCompletedNo Results AvailableKeratitisOther: Hydrogel dressing|Other: Lacrilube ointmenthttps://ClinicalTrials.gov/show/NCT00513734
156332156332Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a ProstatectomyCompletedNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT00513721
156333156333Facilitating Aftercare for Alcohol Detox PatientsCompletedHas ResultsAlcohol Abuse|Alcohol DependenceBehavioral: Motivation Enhancement Therapy (MET)|Behavioral: Peer-Twelve Step Facilitation (P-TSF)https://ClinicalTrials.gov/show/NCT00513708
156334156334Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerActive, not recruitingNo Results AvailableInflammatory Breast Cancer|Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast CancerDrug: sunitinib malate|Drug: paclitaxel|Drug: doxorubicin hydrochloride|Drug: cyclophosphamide|Biological: filgrastim|Procedure: therapeutic conventional surgery|Other: laboratory biomarker analysis|Other: flow cytometryhttps://ClinicalTrials.gov/show/NCT00513695
156335156335Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)CompletedHas ResultsCystic Fibrosis|Pancreatic InsufficiencyDrug: Ultrase® MT20https://ClinicalTrials.gov/show/NCT00513682
156336156336Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in TanzaniaCompletedNo Results AvailableFalciparum MalariaBiological: PEV 301& 302 in virosomes|Biological: Inflexal V (active comparator)https://ClinicalTrials.gov/show/NCT00513669
156337156337A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer PainCompletedNo Results AvailableCancer|Pain|ConstipationDrug: Oxycodone|Drug: Oxycodone/Naloxonehttps://ClinicalTrials.gov/show/NCT00513656
156338156338Metabolic Effect of Insulin Aspart and Human Insulin in Different DosesCompletedNo Results AvailableDiabetes MellitusDrug: insulin aspart|Drug: human regular insulinhttps://ClinicalTrials.gov/show/NCT00513643
156339156339Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery DiseaseCompletedNo Results AvailableType 2 Diabetes|Coronary Artery DiseaseDrug: Glipizide|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT00513630
156340156340Effectiveness of Arginine as a Treatment for Sickle Cell AnemiaCompletedHas ResultsAnemia, Sickle CellDrug: Arginine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00513617
156341156341Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic MelanomaCompletedHas ResultsMelanoma|Malignant Melanoma|Melanoma, Experimental|Experimental MelanomasBiological: aldesleukin|Biological: therapeutic autologous lymphocytes|Drug: Cyclophosphamide|Drug: Fludarabine phosphate|Radiation: Total body irradiationhttps://ClinicalTrials.gov/show/NCT00513604
156342156342Duke Autoimmunity in Pregnancy RegistryRecruitingNo Results AvailablePregnancy|Systemic Lupus Erythematosus|Cutaneous Lupus|Rheumatoid Arthritis|Sjogren's Syndrome|Sclerodermahttps://ClinicalTrials.gov/show/NCT00513591
156343156343Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic SyndromeActive, not recruitingNo Results AvailableMyelodysplastic SyndromesBiological: PR1 leukemia peptide vaccine|Biological: incomplete Freund's adjuvant|Biological: sargramostimhttps://ClinicalTrials.gov/show/NCT00513578
156344156344A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy VolunteersCompletedNo Results AvailableHealthy Subjects|Depressive Disorder and Anxiety DisordersDrug: single dosehttps://ClinicalTrials.gov/show/NCT00513565
156345156345Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium ParatuberculosisRecruitingNo Results AvailableCrohn's DiseaseDrug: Rifabutin, Clarithromycin, and Clofaziminehttps://ClinicalTrials.gov/show/NCT00513552
156346156346Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by SurgeryCompletedNo Results AvailableExtrahepatic Bile Duct Cancer|Gallbladder CancerDrug: porfimer sodium|Procedure: biliary stentinghttps://ClinicalTrials.gov/show/NCT00513539
156347156347Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 InfectionCompletedHas ResultsInfection|Precancerous ConditionBiological: Gardasilhttps://ClinicalTrials.gov/show/NCT00513526
156348156348TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) PreviouslTerminatedNo Results AvailableHIV InfectionsDrug: TMC114 (darunavir) / ritonavirhttps://ClinicalTrials.gov/show/NCT00513513
156349156349Zambia Integrated Management of Malaria and Pneumonia StudyCompletedHas ResultsPneumonia|MalariaDrug: Coartem and amoxicillin|Drug: Coartemhttps://ClinicalTrials.gov/show/NCT00513500
156350156350Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway SensitivityCompletedNo Results AvailableAllergic RhinitisDrug: Dust mite extract, Fluticasone, Methacholinehttps://ClinicalTrials.gov/show/NCT00513487
156351156351Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantCompletedNo Results AvailableChronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsDrug: busulfan|Drug: cyclophosphamide|Drug: cyclosporine|Drug: etoposide|Drug: methotrexate|Drug: rasburicase|Drug: sirolimus|Drug: tacrolimus|Other: diagnostic laboratory biomarker analysis|Other: flow cytometry|Other: immunologic technique|Procedure: allogeneic hematopoietic stem cell transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: total-body irradiationhttps://ClinicalTrials.gov/show/NCT00513474
156352156352S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate in Preventing Liver Cancer in Patients With Chronic Hepatitis C InfectionActive, not recruitingNo Results AvailableAdult Primary Liver Cancer|Hepatitis C InfectionDrug: S-adenosyl-L-methionine disulfate p-toluene-sulfonate|Other: placebo|Other: laboratory biomarker analysis|Other: immunoenzyme technique|Other: high performance liquid chromatographyhttps://ClinicalTrials.gov/show/NCT00513461
156353156353Promoting Physical Activity for Persons With Multiple SclerosisCompletedNo Results AvailableMultiple SclerosisOther: Group wellness intervention|Other: Individualized physical rehabilitationhttps://ClinicalTrials.gov/show/NCT00513448
156354156354Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedHas ResultsMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent SquamoDrug: saracatinib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00513435
156355156355The Long-term Evaluation of Glucosamine Sulphate StudyActive, not recruitingNo Results AvailableOsteoarthritis, KneeDietary Supplement: Glucosamine sulphate and chondroitin|Dietary Supplement: Glucosamine sulphate|Dietary Supplement: Chondroitin sulphate|Dietary Supplement: Placebo capsules for glucosamine and chondroitinhttps://ClinicalTrials.gov/show/NCT00513422
156356156356Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up ScheduleCompletedHas ResultsStreptococcus Pneumoniae and Nontypable Haemophilus Influenzae|Streptococcus Pneumoniae VaccinesBiological: Synflorix|Biological: Infanrix Hexa|Biological: Havrixhttps://ClinicalTrials.gov/show/NCT00513409
156357156357High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant TuberculosisCompletedNo Results AvailableTuberculosis, Multidrug-ResistantDrug: Isoniazid|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00513396
156358156358Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and NeckActive, not recruitingNo Results AvailableSquamous Cell Carcinoma of the Head and NeckDrug: Panitumumab|Drug: Carboplatin|Drug: Paclitaxel|Radiation: Intensity Modulated Radiation Therapy|Drug: 5-Fluorouracil|Drug: Docetaxel|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00513383
156359156359A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of PsoriasisCompletedHas ResultsPsoriasisBiological: Humira (adalimumab)https://ClinicalTrials.gov/show/NCT00513370
156360156360Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer PatientsCompletedHas ResultsGastrointestinal Cancer|Lung CancerDrug: Melatonin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00513357

* Görseller ve İçerik tekif hakkına sahip olabilir